Tuesday , November 21 2017
Home / Conditions / MODY/LADA / Dr. Lou Philipson: Monogenic Diabetes

Dr. Lou Philipson: Monogenic Diabetes

Dr. Lou Philipson, endocrinologist, professor of medicine at The University of Chicago, Medicine and director of the Kovler Diabetes Center, which has been recognized as one of only seven National Institutes of Health (NIH) Diabetes Research and Training Centers in the U.S., discusses monogenic diabetes, how it differentiates from MODY and common misdiagnosis of the condition.

Dr. Lou Philipson from Diabetes in Control, Inc. on Vimeo.

Dr, Lou Philipson is an endocrinologist, professor of medicine at The University of Chicago, Medicine and director of the Kovler Diabetes Center, which has been recognized as one of only seven National Institutes of Health (NIH) Diabetes Research and Training Centers in the U.S. Dr. Philipson’s clinical interests include type 1 diabetes, complicated type 2 diabetes, monogenic diabetes and hypoglycemia.

He and his colleagues discovered rare insulin gene mutations that produce beta cell ER stress and cause neonatal diabetes. In addition, Dr. Philipson and his colleagues are among the nation’s leading experts on monogenic diabetes, following more than 100 patients diagnosed with neonatal diabetes and many others with maturity onset diabetes of the young (MODY) type diabetes. He also serves as co-director of the Human Islet Transplantation project at the University of Chicago.